Alliance Wealth Advisors LLC UT Purchases New Stake in Endava plc (NYSE:DAVA)

Alliance Wealth Advisors LLC UT acquired a new position in shares of Endava plc (NYSE:DAVAFree Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 7,196 shares of the company’s stock, valued at approximately $222,000.

Several other large investors also recently made changes to their positions in DAVA. Precision Wealth Strategies LLC boosted its position in Endava by 4.5% during the 4th quarter. Precision Wealth Strategies LLC now owns 8,954 shares of the company’s stock worth $277,000 after purchasing an additional 383 shares during the period. Robeco Institutional Asset Management B.V. lifted its stake in shares of Endava by 13.9% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 204,300 shares of the company’s stock worth $6,313,000 after purchasing an additional 25,000 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Endava by 28.5% in the fourth quarter. Blue Trust Inc. now owns 1,494 shares of the company’s stock worth $46,000 after buying an additional 331 shares during the period. AEGON ASSET MANAGEMENT UK Plc grew its stake in shares of Endava by 35.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 332,642 shares of the company’s stock valued at $10,282,000 after buying an additional 86,870 shares in the last quarter. Finally, Janney Montgomery Scott LLC purchased a new stake in shares of Endava during the 4th quarter valued at about $783,000. Institutional investors and hedge funds own 62.23% of the company’s stock.

Endava Stock Performance

DAVA opened at $32.39 on Wednesday. Endava plc has a twelve month low of $23.28 and a twelve month high of $72.98. The stock has a market cap of $1.91 billion, a PE ratio of 231.34, a price-to-earnings-growth ratio of 2.29 and a beta of 1.22. The business’s 50 day moving average is $30.82 and its 200-day moving average is $29.10. The company has a current ratio of 1.90, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

Analysts Set New Price Targets

DAVA has been the subject of several recent research reports. Guggenheim lowered their price objective on shares of Endava from $45.00 to $40.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Bank of America started coverage on shares of Endava in a report on Friday, November 22nd. They set a “neutral” rating and a $29.00 price target for the company. Morgan Stanley boosted their price objective on shares of Endava from $33.00 to $35.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st. Citigroup dropped their target price on Endava from $30.00 to $27.00 and set a “neutral” rating on the stock in a research report on Monday, October 28th. Finally, TD Cowen increased their price target on Endava from $35.00 to $36.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $40.01.

View Our Latest Stock Analysis on DAVA

Endava Profile

(Free Report)

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Further Reading

Institutional Ownership by Quarter for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.